Nonsurgical Jowl Treatment Melbourne

What Causes Jowls to Develop?

Jowling is not caused by a single factor, it is the visible outcome of multiple simultaneous anatomical changes that occur over time. Understanding the underlying causes helps explain both why nonsurgical treatment has real limitations and why, in selected patients, it can produce genuinely meaningful improvement.

The primary driver of jowling is ligamentous laxity combined with fat compartment descent. The face contains a network of fibrous ligaments, the osteocutaneous ligaments and retaining ligaments, that suspend soft tissue to the underlying bony and muscular framework. Over time, these ligaments become less taut and lose their ability to hold facial fat in its youthful position. As the ligaments weaken, the fat compartments they supported begin to descend, not falling freely downward, but gradually redistributing over years in ways that change the overall shape of the face.

Bone resorption in the mandible, the lower jaw, contributes importantly to jowl formation. As the mandible loses volume and the angle of the jaw changes over decades, the soft tissue above has less structural foundation to rest on, and the jawline definition that was previously supported by the underlying bone diminishes.

The platysma muscle, the broad, flat muscle that runs from the lower face down to the collarbone, also changes with age. As this muscle loses tone and the skin above it loses elasticity, banding patterns can become visible, and the overall tightness of the lower face and neck skin diminishes.

Deflation of the midcheek fat compartments plays an indirect but important role. As the cheeks lose volume, the skin and soft tissue of the midface has less internal support, making it more susceptible to the effects of gravity and ligamentous laxity. Volume loss in the midface is one of the reasons that strategic filler placement higher up in the face can sometimes have a visible, if modest, effect on jowl appearance.

Genetics, UV exposure history, skin quality, body weight fluctuations, and cumulative facial movement all influence the rate and degree of jowl development in any individual.

The Limits of nonsurgical Treatment for Jowling

Before discussing what nonsurgical treatment can achieve, it is important to be clear eyed about its limitations, because this is an area where patient expectations need to be carefully calibrated.

The fundamental driver of established jowling, skin laxity and the descent of soft tissue below the mandibular border, is, at a certain degree of development, beyond the corrective capacity of any injectable treatment. Surgical approaches including lower face and neck lifting procedures address this by physically repositioning and resuspending descended soft tissue. Injectable treatments cannot do this. They work at the level of adding volume, providing structural support to overlying tissue, and improving surface contour, not by lifting or suspending fallen tissue.

This means that nonsurgical jowl treatment is generally most appropriate for patients with mild to moderate jowling, good baseline skin quality, and specific anatomical deficits, such as pre jowl hollowing or midcheek volume loss, that are contributing to the appearance of the jowl. For patients with severe jowling, very lax skin, or heavy lower face tissue, nonsurgical treatment is unlikely to produce meaningful improvement, and a discussion about surgical options with a facial plastic surgeon is often more appropriate.

There is also a risk of worsening the appearance with overly aggressive filler treatment in the lower face. Heavy filler placement in the jowl area itself can add bulk and heaviness that makes the lower face look larger rather than more defined. This is one of the reasons that a thorough anatomical assessment before any lower face filler placement is essential.

How Injectable Treatment Can Address Jowl Concerns

Within its anatomical scope and limitations, injectable filler treatment can produce genuine and meaningful improvement in the appearance of mild to moderate jowling through several specific mechanisms.

Pre jowl sulcus filling is one of the most commonly used approaches. The pre jowl sulcus is the hollow that forms between the jowl and the chin as the mandible resorbs and the soft tissue descends. Filling this hollow with a small volume of filler in the appropriate tissue plane can blur the transition between the jowl and the chin, reducing the apparent step that makes jowling visually prominent. This is not correcting the jowl itself, it is improving the visual contour between the jowl and the chin structure.

Midcheek volume restoration addresses the indirect contribution of midface volume loss to jowl appearance. When the midcheek fat compartments are deflated, the lower face can appear relatively heavier by comparison, accentuating the jowl. Restoring a degree of midcheek volume lifts the visual weight of the face toward the upper midface, which can reduce the relative prominence of jowling. This approach works best in patients where midface deflation is a genuine contributor to the jowl appearance, not simply as a general technique for all presentations.

Jawline definition filler involves placing product along the mandibular border to re establish a crisper visual jawline. This approach can improve the definition of the jaw in some patients but carries higher vascular risk in an anatomically complex area and must only be performed by practitioners with appropriate training in lower face anatomy and safe product placement technique.

The combination of approaches used, and whether any treatment is appropriate at all, is determined by thorough assessment of the individual patient’s anatomy, degree of jowling, skin quality, and expected response to treatment.

The Role of anti-wrinkle Treatment in Lower Face Concerns

anti-wrinkle injectable treatments have a more limited but potentially useful role in addressing certain aspects of lower face and jowl related concerns. These treatments work by reducing the activity of specific muscles, and in the lower face, several muscles can contribute to the appearance of jowling and lower face ageing when they are particularly active.

The depressor anguli oris muscle, a muscle that pulls the corners of the mouth downward, can contribute to a permanently downturned mouth expression in some individuals. Carefully targeted treatment of this muscle can soften the downturned appearance, improving the overall balance of the lower face and indirectly affecting the visual impression of jowling.

The platysma bands, vertical lines or cords that appear on the neck due to platysmal muscle activity, are a related concern that becomes more prominent as the neck skin loses elasticity. Treatment of prominent platysmal bands with anti-wrinkle injections can reduce the appearance of these cords, improving the visual transition from the lower face to the neck. This is sometimes referred to as a nonsurgical neck treatment, though its effect on jowls themselves is indirect.

Masseter treatment, reducing the activity of the chewing muscle on the sides of the lower face, can narrow the apparent width of the lower face in patients with prominent masseter muscles. This does not directly address jowling, but in patients where the lower face appears wide and heavy partly due to masseter bulk, treatment can contribute to an overall improvement in lower face proportions.

The role of each of these treatments in any individual patient’s case needs to be assessed specifically during the consultation. Not all lower face concerns benefit from all treatments, and a treatment plan should be driven by assessment of what is anatomically causing the specific concern, not by a generic lower face protocol.

Assessment: What the Consultation Examines

A thorough consultation for jowl concerns involves a structured assessment of multiple anatomical factors, not simply looking at the jowl in isolation. Understanding the full context is essential for determining whether nonsurgical treatment is appropriate and, if so, what approach is most likely to be helpful.

The degree of jowling is the first consideration. Mild jowling with good baseline skin quality and specific volume deficits that are contributing to the appearance is very different from severe jowling with significant skin laxity in a patient who has not yet had any assessment. The former may be appropriate for nonsurgical treatment; the latter is more likely to benefit from a surgical consultation.

Skin quality assessment examines elasticity, thickness, and the degree of surface textural change. Skin with good remaining elasticity tends to respond more favourably to volume replacement than skin that is highly lax, when lax skin is given more volume beneath it, the result can sometimes be a heavier appearance rather than an improved contour.

Facial anatomy in three dimensions is assessed, not just the surface appearance but the underlying bone structure, the distribution and degree of fat compartment deflation, and the position of key anatomical landmarks that are important for safe treatment planning. The lower face is a region with significant vascular and nerve anatomy, and treatment planning in this area requires careful respect for these structures.

Patient history, including any previous injectable treatment in the lower face, any history of herpes simplex in or near the treatment area, medications that affect bleeding, and general medical history, is reviewed as part of the consultation.

Final assessment may be that the patient is not a suitable candidate for nonsurgical treatment of their jowl concern at this time, or that the degree of jowling warrants a surgical consultation before any injectable treatment is considered. This is honest clinical advice, given in the patient’s genuine interest.

What to Expect from nonsurgical Jowl Treatment

For patients who are assessed as appropriate candidates for nonsurgical jowl treatment, it is important to have a realistic and well informed understanding of what the treatment experience and the results are likely to involve.

The treatment itself typically involves the placement of dermal filler in one or more of the areas described, the pre jowl sulcus, the midcheek, and/or the jawline, using a combination of sharp needle and blunt cannula technique depending on the specific anatomical area and the practitioner’s assessment of the safest approach. The procedure is generally completed in a single appointment, though some patients may require more than one session to achieve the level of improvement they are seeking.

Immediate post treatment swelling is common, particularly in the lower face, and can temporarily exaggerate the appearance of the treated areas before it settles. Most of the initial swelling resolves within a week, though subtle swelling can persist for several weeks in some patients. Bruising is possible, particularly with needle based techniques, and may be visible for several days to two weeks.

The full result, with all initial swelling resolved and the filler fully integrated into the tissue, typically becomes apparent four to six weeks after treatment. Review appointments at this timeframe are important for assessing the result accurately and determining whether any further treatment would be beneficial.

Results are not permanent. Filler products used in the lower face are metabolised over time by the body, and the clinical duration of the result varies between individuals and depending on the product and volume used. Maintenance treatment every twelve to twenty four months is typical, though this varies. Individual results cannot be absolute, and the degree of improvement achievable depends on the specific anatomy.

When Surgical Consultation Is More Appropriate

Honest guidance about when nonsurgical treatment is not the most appropriate path is an important part of any responsible aesthetic consultation for jowl concerns. There is a point at which the degree of skin laxity, soft tissue descent, and structural change means that surgical intervention, typically a lower face and neck lift, is the only approach with sufficient capacity to produce meaningful correction.

Patients with severe jowling where the tissue has descended significantly below the mandibular border, those with extensive skin laxity along the jawline and into the neck, and those who have tried nonsurgical approaches without achieving satisfactory results are typically better served by a conversation with a facial plastic surgeon or plastic surgeon experienced in lower face surgery than by repeated injectable treatment.

This is not a failure of nonsurgical treatment, it is an honest acknowledgement of the anatomical boundaries within which injectable treatment works. A practitioner who recommends surgical consultation when it is genuinely appropriate is serving the patient’s interests far better than one who continues to treat with injectables in the hope of achieving results that are beyond their realistic capacity to deliver.

At Core Aesthetics, the assessment will include an honest opinion about where on the spectrum of jowl severity a patient sits, and whether nonsurgical treatment is likely to produce results that are meaningful and proportionate to the investment of time, recovery, and cost. Patients for whom surgical consultation is recommended will be provided with this guidance clearly and without hesitation.

Maintaining Results and long-term Planning

For patients who achieve a good result from nonsurgical jowl treatment, the question of how to maintain and build on that result over time is an important part of the ongoing conversation.

Filler placed in the lower face does not last indefinitely. Depending on the product, the volume placed, and individual metabolic factors, the result typically requires review and possibly repeat treatment within twelve to twenty four months. Review appointments between treatment sessions allow the practitioner to monitor the ongoing result, assess how the underlying anatomy is continuing to change, and make recommendations about whether and when further treatment is appropriate.

As facial ageing continues over time, the treatment approach may need to evolve. Factors that change include the degree of bony resorption, the extent of fat compartment deflation, the quality of the overlying skin, and the position and extent of the jowl itself. A treatment plan that was appropriate two or three years ago may need to be reconsidered in light of these changes.

Cumulative filler load in the lower face is an important consideration in long-term planning. Multiple rounds of filler placement in the same region over many years can, if not carefully managed, contribute to tissue heaviness and changes in tissue quality that are difficult to reverse. A practitioner who is thinking about this responsibly will avoid simply adding more product at each visit and will instead periodically reassess whether the total volume of filler in the region is appropriate or whether some dissolving of prior filler is warranted before any new placement.

Sun protection, skincare, and general lifestyle factors continue to matter over the long-term. Protecting skin from UV exposure, maintaining skin quality with appropriate topical products, and avoiding habits like smoking that accelerate skin ageing all contribute to preserving the results of injectable treatment for longer.

Why Injectable Specialist Assessment Matters for the Lower Face

The lower face is one of the highest risk regions for injectable treatment because of the density and variability of its vascular anatomy. The facial artery, submental artery, and their branches run through the lower face in patterns that vary meaningfully between individuals. Injections in the wrong plane, at the wrong depth, or without appropriate knowledge of vascular anatomy carry risks including vascular occlusion, the blockage of a blood vessel by injected product, which can lead to tissue damage if not recognised and managed promptly.

This risk profile means that lower face injectable treatment is specifically not an appropriate area for practitioners without thorough training in facial anatomy and vascular risk management. The AHPRA September 2025 guidelines require that registered health practitioners performing nonsurgical cosmetic procedures demonstrate appropriate clinical competence, and the lower face is an area where this competency requirement is particularly significant.

At Core Aesthetics, all treatment is performed by Corey Anderson, a Registered Nurse with AHPRA registration and a focus on injectable only, anatomy led practice. The emphasis on conservative dosing, appropriate product selection, careful anatomical assessment, and knowledge of how to recognise and manage adverse events reflects the requirements for safe practice in this region.

Patients who are considering lower face treatment at any clinic should ask about the practitioner’s specific training in lower face anatomy, their approach to vascular risk management, and what their process is in the event of an adverse event. These are entirely appropriate questions, and a practitioner committed to patient safety will answer them with clarity and without defensiveness.